News Praxis soars on rare childhood epilepsy trial data Praxis looks like it could be filing for approval of two products next year, after its childhood epilepsy drug delivered a win in a pivotal trial.
News Wearable alert system for epileptics set for European launch An AI-powered wearable device that warns people with epilepsy about an impending seizure will launch in Europe next year.
News Angelini taps Sovargen for epilepsy drug in $550m deal Angelini Pharma has licensed a preclinical-stage mTOR inhibitor from South Korean biotech Sovargen with potential for genetic forms of epilepsy.
R&D Navigating the unique challenges of epilepsy in women's heal... Epilepsy affects women differently than men, owing to the complexity of brain health and the historical lack of investment in women’s health.
News Case builds for Biogen, Stoke's Dravet syndrome drug Hopes have risen for a new treatment for severe childhood epilepsy Dravet syndrome, on the back of new data for Biogen and Stoke's zorevunersen.
News AI tool detects brain lesions linked to epilepsy Researchers developed an artificial intelligence-powered tool that was able to detect two-thirds of epilepsy brain lesions missed by radiologists.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.